Global /China /Healthcare /Drug Manufacturers - General /600085

Beijing Tongrentang Co., Ltd.

600085

• SSE: 600085 • Delayed

27.77CNY 1.4%

4.10 USD

As of 6 June 2026, Beijing Tongrentang Co., Ltd. has a market cap of $5.63B USD, ranking #3448 globally and #631 in China. It ranks #254 in the Healthcare sector, and #99 in the Drug Manufacturers - General industry.

Global Rank

3448

Country Rank

631

Sector Rank

254

Industry Rank

Key Stats

Market Cap

$5.63BUSD

38.09B CNY

Enterprise Value

$5.68BUSD

38.5B CNY

Revenue (TTM)

$2.46BUSD

16.64B CNY

EBITDA (TTM)

$301.49MUSD

2.04B CNY

Net Income (TTM)

$159.29MUSD

1.08B CNY

EBITDA Margin

12%

Profit Margin

6.5%

PE Ratio

35.3

Forward PE

26.8

PS Ratio

2.3

PB Ratio

1.8

EV/EBITDA

14.3

Company Profile

Country (HQ)

China

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Chaohua Zhang open_in_new

Employees

17,284

Founded

1997

Website

gf.tongrentang.com open_in_new

warningChart data may be delayed

1d	1w	1m	3m	6m	YTD	1y	3y	5y
1.4%	0.3%	-1.8%	-10%	-18%	-14%	-22%	-52%	-2.7%

News

Markets

Exchange	Ticker	Price	Quotes
Shanghai Stock Exchange (SSE / SHA) MIC: XSHG PRIMARY	600085 北京同仁堂股份有限公司 Class A ISIN: CNE000000R69 Shares Out.: Shares Outstanding: 1.371B¹ Shares Float: 610.787M² TV: TradingView: SSE: 600085 SA: Stock Analysis: SHA: 600085 YF: Yahoo Finance: 600085.SS GF: Google Finance: SHA: 600085 BA: Barron's: 600085 MS: Morningstar: XSHG: 600085	27.77 CNY	TV: TradingView: SSE: 600085 SA: Stock Analysis: SHA: 600085 YF: Yahoo Finance: 600085.SS GF: Google Finance: SHA: 600085 BA: Barron's: 600085 MS: Morningstar: XSHG: 600085

¹Market cap is calculated using shares outstanding.

²Float shares are publicly tradable shares, excluding insider-held stock.

About Beijing Tongrentang Co., Ltd.

Beijing Tongrentang Co., Ltd engages in the production and sale of traditional Chinese medicine preparations in China and internationally. The company offers various product dosage forms, such as pills, powders, medicated wines, capsules, oral liquids, and drop pills. Its products are used for cardiovascular, cerebrovascular, gynecology, heat-clearing, respiratory system, nourishing and calming, digestive, pediatrics, wind-dispelling and dampness removing, orthopedics, facial features, dermatological surgery, mental health, and food and beverages applications. The company was founded in 1997 and is based in Beijing, China. Beijing Tongrentang Co., Ltd operates as a subsidiary of China Beijing Tong Ren Tang Group Co. Ltd.

Similar Companies

Industry: Drug Manufacturers - General (China)

Name	Market Cap (USD) diff.	PE	Country
Jiangsu Hengrui Pharmaceuticals Co.,Ltd SSE: 600276	$53.9B 364.89B CNY 858%	44.9	China
WuXi AppTec Co., Ltd. SSE: 603259	$49.69B 336.36B CNY 783%	17.2	China
Hansoh Pharmaceutical Group Company Ltd. SHEK: 3692	$28.52B 223.48B HKD 407%	35.7	China
Innovent Biologics, Inc. SHEK: 1801	$18.8B 147.32B HKD 234%	162.3	China
Sichuan Biokin Pharmaceutical Co.,Ltd. SSE: 688506	$16.53B 111.89B CNY 194%	-	China
Akeso, Inc. SHEK: 9926	$16.01B 125.46B HKD 185%	-	China

Industry: Drug Manufacturers - General (Global)

Name	Market Cap (USD) diff.	PE	Country
Eli Lilly and Co. NYSE: LLY	$761.68B 13K%	38.1	United States
Johnson & Johnson NYSE: JNJ	$547.28B 10K%	26.4	United States
AbbVie Inc. NYSE: ABBV	$360.63B 6K%	97.4	United States
Roche Holding AG SIX: RO	$324.68B 256.25B CHF 6K%	19.9	Switzerland
AstraZeneca PLC LSE: AZN	$289.43B 215.59B GBP 5K%	27.6	United Kingdom
Novartis AG SIX: NOVN	$277.35B 218.9B CHF 5K%	20.5	Switzerland

chevron_leftBack